Azithromycin: An Underappreciated Quinolone-Sparing Oral Treatment for Pseudomonas aeruginosa Infections

Outpatient treatment of Pseudomonas aeruginosa infections is challenged by increasing rates of resistance to fluoroquinolones, the only class of antibiotics which offers an established oral route of administration against this organism. Azithromycin does not demonstrate activity against P. aeruginos...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulloa, Erlinda R., Sakoulas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024921/
https://www.ncbi.nlm.nih.gov/pubmed/35453266
http://dx.doi.org/10.3390/antibiotics11040515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024921/
https://www.ncbi.nlm.nih.gov/pubmed/35453266
http://dx.doi.org/10.3390/antibiotics11040515

Ejemplares similares